Orally bioavailable antagonists of inhibitor of apoptosis proteins based on an azabicyclooctane scaffold.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2009-02-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm801450cPMID 19228017
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fragment-based design of small molecule X-linked inhibitor of apoptosis protein inhibitors.

  2008cited by this paper
• Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation

  2008cited by this paper
• c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation*

  2008cited by this paper
• cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.

  2008cited by this paper
• IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

  2007cited by this paper
• IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.

  2007cited by this paper
• The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer

  2007cited by this paper
• The Inhibitor of Apoptosis Protein Fusion c-IAP2·MALT1 Stimulates NF-κB Activation Independently of TRAF1 AND TRAF2*

  2006cited by this paper
• Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.

  2006cited by this paper
• Promoting apoptosis as a strategy for cancer drug discovery

  2005cited by this paper
• Promoting apoptosis as a strategy for cancer drug discovery

  2005cited by this paper
• Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.

  2005cited by this paper
• Non-peptidic small molecule inhibitors of XIAP.

  2005cited by this paper
• Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database.

  2004cited by this paper
• A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.

  2004cited by this paper
• Structure-based design of potent, conformationally constrained Smac mimetics.

  2004cited by this paper
• A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death

  2004cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

  2004cited by this paper
• Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.

  2004cited by this paper
• Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM).

  2004cited by this paper
• Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.

  2004cited by this paper
• Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction.

  2003cited by this paper
• IAP proteins: blocking the road to death's door

  2002cited by this paper
• ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.

  2000cited by this paper
• CAVEAT: A program to facilitate the design of organic molecules

  1994cited by this paper

• Preservation of dendritic D2 receptor transmission in substantia nigra dopamine neurons with age

  2023cites this paper
• Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist

  2023cites this paper
• Effects of age and sex on dendritic D2 autoreceptor inhibition in substantia nigra dopamine neurons

  2022cites this paper
• Functionalized 2‐Hydroxybenzaldehyde‐PEG Modules as Portable Tags for the Engagement of Protein Lysine ϵ‐Amino Groups

  2021cites this paper
• Structure-based design, synthesis, and evaluation of the biological activity of novel phosphoroorganic small molecule IAP antagonists

  2020cites this paper
• Stability and Cell Permeability of Sulfonyl Fluorides in the Design of Lys‐Covalent Antagonists of Protein‐Protein Interactions

  2020cites this paper
• The multiple roles of the IAP super-family in cancer.

  2020cites this paper
• Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives.

  2019cites this paper
• Aryl-fluorosulfate-based Lysine Covalent pan-Inhibitors of Apoptosis Proteins (IAP) Antagonists with Cellular Efficacy.

  2019cites this paper
• Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues.

  2019cites this paper
• Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach.

  2018cites this paper
• Investigating the adverse effects of novel tumour-specific IAP antagonists

  2017cites this paper
• ALANINE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCATED METHODS OF USE CROSS-REFERENCE TO RELATED APPLICATIONS

  2017cites this paper
• Protein–Protein Interaction Inhibitors in Cancer

  2017cites this paper
• Targeting Protein Synthesis, Folding, and Degradation Pathways in Cancer

  2017cites this paper
• Engineering Archeal Surrogate Systems for the Development of Protein–Protein Interaction Inhibitors against Human RAD51

  2016cites this paper
• Novel SMAC Mimetics as Peptide-based Small Molecule Inhibitors of IAPs to Induce Apoptosis in Cancer Cells

  2015cites this paper
• Small molecule modulators of protein-protein interactions: selected case studies.

  2014cites this paper
• Potent and Selective Small-Molecule Inhibitors of cIAP1/2 Proteins Reveal That the Binding of Smac Mimetics to XIAP BIR3 Is Not Required for Their Effective Induction of Cell Death in Tumor Cells

  2014cites this paper
• Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0152 in human plasma using solid-phase extraction.

  2013cites this paper
• Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAP.

  2013cites this paper
• IAP proteins as targets for drug development in oncology

  2013cites this paper
• Classification of scaffold-hopping approaches.

  2012cites this paper
• Computational methods for scaffold hopping

  2012cites this paper
• Targeting IAP proteins for therapeutic intervention in cancer

  2012cites this paper
• From laptop to benchtop to bedside: structure-based drug design on protein targets.

  2012cites this paper
• Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152).

  2012cites this paper
• Inhibitor of apoptosis proteins: fascinating biology leads to attractive tumor therapeutic targets.

  2011cites this paper
• Solid-phase synthesis of smac peptidomimetics incorporating triazoloprolines and biarylalanines.

  2011cites this paper
• Scaffold-hopping provides both a conceptual and practical route for generating new lead series and chemistries with improved efficacy and pharmacokinetic properties based on known drugs and drug-target interactions.

  2011cites this paper
• The Discovery and Development of Smac Mimetics—Small-Molecule Antagonists of the Inhibitor of Apoptosis Proteins

  2011cites this paper
• Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.

  2011cites this paper
• Solid-phase synthesis of an apoptosis-inducing tetrapeptide mimicking the Smac protein

  2011cites this paper
• Targeting IAPs as an approach to anti-cancer therapy.

  2011cites this paper
• New and unusual scaffolds in medicinal chemistry.

  2011cites this paper
• Design of Peptidomimetics

  2010cites this paper
• Small-molecule pan-IAP antagonists: a patent review

  2010cites this paper
• Antagonists of inhibitor of apoptosis proteins based on thiazole amide isosteres.

  2010cites this paper
• Importance of ligand reorganization free energy in protein-ligand binding-affinity prediction.

  2009cites this paper
• Targeting inhibitor of apoptosis proteins for therapeutic intervention.

  2009cites this paper
• Advances and Applications in Bioinformatics and Chemistry Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress Computer Applications for Prediction of Protein–protein Interactions and Rational Drug Design

  year unknowncites this paper